Do COVID-19 RNA-based vaccines put at risk of immune-mediated diseases? In reply to "potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases"

Do COVID-19 RNA-based vaccines put at risk of immune-mediated diseases? In reply to "potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases"

Bibliographische Detailangaben
Veröffentlicht in:Clinical immunology (Orlando, Fla.). - 1999. - 224(2021) vom: 01. März, Seite 108665
1. Verfasser: Talotta, Rossella (VerfasserIn)
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2021
Zugriff auf das übergeordnete Werk:Clinical immunology (Orlando, Fla.)
Schlagworte:Letter Comment Autoimmunity Autoinflammation COVID-19 Immune response SARS-CoV-2 Type I interferon mRNA vaccine COVID-19 Vaccines mehr... RNA 63231-63-0
Beschreibung
Beschreibung:Date Completed 19.02.2021
Date Revised 21.12.2022
published: Print-Electronic
CommentOn: Clin Immunol. 2020 Aug;217:108480. - PMID 32461193
Citation Status MEDLINE
ISSN:1521-7035
DOI:10.1016/j.clim.2021.108665